Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 801 results for "genentech"

Genentech Alzheimer's Drug Misses Goals in Studies
New Indian Express

Genentech to Speak at Pharmica Consulting's West Coast SharePo...

Pharmica Consulting, the industry leader in life science processes and technology, is pleased to announce that Naseem Buckley of Genentech will speak at Pharmica's SharePoint Conference for the Life Sciences Industry on September 30th and October ... Benzinga.com, 20 hours ago
Priority review for Avastin Seeking Alpha, 2 days ago
Priority Review For Genentech's Avastin American Journal of Managed Care, 2 days ago
[x]  

66 images for genentech

Pharmafocus, 6 days ago
Southtown Star, 1 week ago
Drug Discovery and Development, 2 days ago
KXXV-TV, 9 hours ago
Mail.com, 1 week ago
Xconomy, 6 days ago
New Indian Express, 1 week ago
WDBJ7.com, 1 week ago
Drug Discovery and Development, 1 week ago
San Francisco Business Times, 1 week ago
Pharmafocus

Mixed bag for Genentech dementia drug

A Phase II clinical trial for Genentech's investigational Alzheimer's drug failed to meet its primary endpoints but the company and campaigners have pointed to a possible chink of light in the results. The data on amyloid antibody agent ...
 Pharmafocus6 days ago Mixed results for Genentech Alzheimer's drug  San Francisco Chronicle1 week ago Genentech's Alzheimer's drug has mixed results in trials  San Francisco Chronicle1 week ago Should Roche's Failed Trial Give Hope To Alzheimer's Patients?  BioSpace1 week ago
[x]  

Melanoma combination therapy study shows promising results

Genentech has announced that its phase 3 coBRIM study, evaluating the safety and efficacy of a combination of cobimetinib and vemurafenib for the treatment of melanoma, has met its primary endpoint. Genentech, a Roche company, studied the ...
 Dermatology Times1 day ago Genentech's Phase III melanoma study meets primary endpoint  Individual.com1 week ago

Over Half of Audited Multiple Sclerosis Patients Currently Treated with Biogen Idec's Tecfidera Have Experienced Minor Side Effects Although Impact on Use Appears Muted

Genzyme/Sanofi's Lemtrada and Genentech/Roche's Ocrelizumab Will Likely Be Reserved for Patients with Aggressive/Severe MS, According to Findings from Decision Resources Group BURLINGTON, Mass., July 22, 2014 /PRNewswire/ — Decision Resources ...
 Red Orbit1 day ago
[x]  

Study Results from Genentech, Inc. Update Understanding of Neutral Amino Acids (An allosteric switch for pro-HGF/Met signaling using zymogen...

Study Results from Genentech, Inc. Update Understanding of Neutral Amino Acids (An allosteric switch for pro-HGF/Met signaling using zymogen activator peptides) By a News Reporter-Staff News Editor at Life Science Weekly -- Investigators publish ...
 4 Traders1 day ago

Findings from Genentech, Inc. in the Area of Chemotherapy Described (B Cells Regulate Macrophage Phenotype and Response to Chemotherapy in Squamous...

Findings from Genentech, Inc. in the Area of Chemotherapy Described (B Cells Regulate Macrophage Phenotype and Response to Chemotherapy in Squamous Carcinomas) By a News Reporter-Staff News Editor at Biotech Week -- A new study on Drugs and ...
 4 Traders1 day ago Studies from Genentech, Inc. Add New Findings in the Area of Basal Cell Cancer (Systematic Review of Vismodegib Toxicity Profile in the Treatment of...  4 Traders1 week ago

Investigators at Genentech, Inc. Discuss Findings in Rheumatoid Arthritis (Patients' Willingness to Trade Off Between the Duration and Frequency of...

Investigators at Genentech, Inc. Discuss Findings in Rheumatoid Arthritis (Patients' Willingness to Trade Off Between the Duration and Frequency of Rheumatoid Arthritis Treatments) By a News Reporter-Staff News Editor at Health & Medicine Week -- ...
 4 Traders1 day ago

ARVO Foundation Invites Applications for Genentech Age-Related Macular Degeneration Research Fellowships

Deadline: September 30, 2014 The ARVO Foundation for Eye Research , the philanthropic arm of the Association of Research in Vision and Ophthalmology , is inviting applications for two Genentech Age-Related Macular Degeneration Research ...
 Philanthropy News Digest2 days ago
Trade Arabia

Roche CEO No appetite for expensive megadeals here

Genentech it didn't already own for $47 billion. Since then, Roche has racked up a series of smaller pharma and biotech buyouts, mostly aimed at restocking its pipeline as its older
 Big News Network3 days ago Roche CEO: No appetite for expensive megadeals here  FiercePharma3 days ago Takeovers ruled out  Gulf Daily News5 days ago Roche CEO plans to steer clear of big acquisitions  Reuters UK5 days ago
[x]  
Xconomy

West Coast Biotech Roundup: Genentech, CareDx, and More

The week started amid anticipation of a new round of public debuts, with six of the 11 companies queued up coming from the life sciences, according to Renaissance Capital. Then on Tuesday, the Federal Reserve singled out two sectors as overvalued: ...
 Xconomy6 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less